The filing excerpts provided do not contain sufficient business description content to produce a SEC-grounded company summary for Definium Therapeutics Inc (DFTX). The excerpts include only the table of contents and header information from the 10-K filed 2026-02-26 (accession 000119312526076742), without substantive text from Item 1 Business, financial statements, or any other sections that would support factual claims about the company's business model, revenue streams, products, customers, competitors, or geographic footprint. A canonical description cannot be written without misrepresenting unsupported facts.

Source: SEC 10-K, filed 2026-02-26

Industry: Medicinal Chemicals & Botanical Products Peers: Milestone Pharmaceuticals Inc